| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 4, 2024 | Oct 8, 2024 | X4 Pharmaceuticals, Inc | Chief Scientific Officer | Sell | 91.3 | +153,725 | 65.61% | ✓ | $43.3K |
| Mar 11, 2024 | Mar 11, 2024 | X4 Pharmaceuticals, Inc | Chief Scientific Officer | Sell | 36.3 | -14,235 | -5.73% | ✓ | $12.6K |
| Feb 12, 2024 | Feb 12, 2024 | X4 Pharmaceuticals, Inc | Chief Scientific Officer | Sell | 53.8 | -787 | -0.32% | ✓ | $792.7 |
| Nov 1, 2023 | Nov 3, 2023 | X4 Pharmaceuticals, Inc | Chief Scientific Officer | Sell | 18.8 | -67,695 | -21.35% | ✓ | $49.4K |
| Mar 10, 2023 | Mar 13, 2023 | X4 Pharmaceuticals, Inc | Chief Scientific Officer | Sell | 23.8 | -16,806 | -16.29% | ✓ | $14.1K |
| Feb 13, 2023 | Feb 15, 2023 | X4 Pharmaceuticals, Inc | Chief Scientific Officer | Sell | 52.5 | -928 | -0.89% | ✓ | $863 |